UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Survival of HER2-positive advanced breast cancer patients treated with lapatinib plus capecitabine: A national population-based study: Long-term analysis

Annals of oncology, 2018-10, Vol.29, p.viii105-viii105

2018

Volltextzugriff (PDF)

STELLAR: Final updated results of a phase II trial of TTFields with chemotherapy for unresectable malignant pleural mesothelioma

Annals of oncology, 2019-04, Vol.30, p.ii72-ii72

2019

Volltextzugriff (PDF)

STELLAR: Final results of a phase II trial of TTFields with chemotherapy for first-line treatment of pleural mesothelioma

Annals of oncology, 2018-10, Vol.29, p.viii641-viii641

2018

Volltextzugriff (PDF)

VP5-2021: IMpower133: Gene expression (GE) analysis in long-term survivors (LTS) with ES-SCLC treated with first-line carboplatin and etoposide (CE) ± atezolizumab (atezo)

Annals of oncology, 2021-08, Vol.32 (8), p.1063-1065

2021

Volltextzugriff (PDF)

327PSurvival of HER2-positive advanced breast cancer patients treated with lapatinib plus capecitabine: A national population-based study: Long-term analysis

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

196OSTELLAR: Final updated results of a phase II trial of TTFields with chemotherapy for unresectable malignant pleural mesothelioma

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

1807PSTELLAR: Final results of a phase II trial of TTFields with chemotherapy for first-line treatment of pleural mesothelioma

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Oral vinorelbine (NVBo) at 3-weekly flat-dose intakes (FDI) as single agent or with cisplatin (CDDP) concomitantly with thoracic radiotherapy (RT) in stage III NSCLC: Escalation-dose phase I trial results

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7045-7045

2011

Volltextzugriff (PDF)

Prognostic score for second-line chemotherapy of advanced non-small cell lung cancer (NSCLC): External validation in a phase III trial comparing vinflunine with docetaxel

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7556-7556

2011

Volltextzugriff (PDF)

Pulmonary metastasectomy in soft tissue sarcomas (STS): A single-institution experience

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10088-10088

2011

Volltextzugriff (PDF)

Efficacy and safety of PF299804 versus erlotinib (E): A global, randomized phase II trial in patients (pts) with advanced non-small cell lung cancer (NSCLC) after failure of chemotherapy (CT)

Journal of clinical oncology, 2010-06, Vol.28 (18_suppl), p.LBA7523-LBA7523

2010

Volltextzugriff (PDF)

Final efficacy results from OAM4558g, a randomized phase II study evaluating MetMAb or placebo in combination with erlotinib in advanced NSCLC

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7505-7505

2011

Volltextzugriff (PDF)

Combined treatment of patients with incompletely resected invasive thymoma: A retrospective analysis

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.18193-18193

2007

Volltextzugriff (PDF)

Co-expression of steroid and HER2 receptors in breast carcinomas in a large (4,493 cases) population-based Polish study

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.797-797

2005

Volltextzugriff (PDF)

A pilot study of concurrent chemotherapy (teniposide and carboplatin) combined with whole brain radiotherapy in non-small cell lung cancer patients with brain metastases

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7332-7332

2004

Volltextzugriff (PDF)

A pilot study of concurrent chemotherapy (teniposide and carboplatin) combined with whole brain radiotherapy in non-small cell lung cancer patients with brain metastases

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7332-7332

2004

Volltextzugriff (PDF)

Combination chemotherapy in squamous cell carcinoma of the lung

Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984-04, Vol.3 (2), p.75

1984

Volltextzugriff (PDF)

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

The New England journal of medicine, 2018-12, Vol.379 (23), p.2220-2229

2018

Volltextzugriff (PDF)

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

The Lancet (British edition), 2009-10, Vol.374 (9699), p.1432-1440

2009

Volltextzugriff (PDF)

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

The lancet oncology, 2012, Vol.13 (1), p.33-42

2012

Volltextzugriff (PDF)

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Journal of clinical oncology, 2003-08, Vol.21 (16), p.3150-3157

2003

Volltextzugriff (PDF)

Transmission et équation trans-personnelle de l’analyste

Revue française de psychanalyse, 2024-06, Vol.88 (4), p.105-115

Krzakowski, Piotr

2024

Volltextzugriff (PDF)

Pathophysiology and clinical characteristics of pain in most common locations in cancer patients

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2016-12, Vol.67 (6), p.787

2016

Volltextzugriff (PDF)

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)

Annals of oncology, 2015-08, Vol.26 (8), p.1734-1740

2015

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(131)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(42)
Science & Technology
(42)
Humans
(40)
Oncology
(38)
Female
(31)
Middle Aged
(31)
Male
(27)
Aged
(26)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Adult
(23)
Lung Neoplasms - Drug Therapy
(20)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(19)
Chemotherapy
(19)
Lung Neoplasms - Pathology
(17)
Treatment Outcome
(16)
Carcinoma, Non-Small-Cell Lung - Pathology
(15)
Pharmacology. Drug Treatments
(15)
Antineoplastic Agents
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Survival of HER2-positive advanced breast cancer patients treated with lapatinib plus capecitabine: A national population-based study: Long-term analysis

STELLAR: Final updated results of a phase II trial of TTFields with chemotherapy for unresectable malignant pleural mesothelioma

STELLAR: Final results of a phase II trial of TTFields with chemotherapy for first-line treatment of pleural mesothelioma

VP5-2021: IMpower133: Gene expression (GE) analysis in long-term survivors (LTS) with ES-SCLC treated with first-line carboplatin and etoposide (CE) ± atezolizumab (atezo)

327PSurvival of HER2-positive advanced breast cancer patients treated with lapatinib plus capecitabine: A national population-based study: Long-term analysis

196OSTELLAR: Final updated results of a phase II trial of TTFields with chemotherapy for unresectable malignant pleural mesothelioma

1807PSTELLAR: Final results of a phase II trial of TTFields with chemotherapy for first-line treatment of pleural mesothelioma

Oral vinorelbine (NVBo) at 3-weekly flat-dose intakes (FDI) as single agent or with cisplatin (CDDP) concomitantly with thoracic radiotherapy (RT) in stage III NSCLC: Escalation-dose phase I trial results

Prognostic score for second-line chemotherapy of advanced non-small cell lung cancer (NSCLC): External validation in a phase III trial comparing vinflunine with docetaxel

Pulmonary metastasectomy in soft tissue sarcomas (STS): A single-institution experience

Efficacy and safety of PF299804 versus erlotinib (E): A global, randomized phase II trial in patients (pts) with advanced non-small cell lung cancer (NSCLC) after failure of chemotherapy (CT)

Final efficacy results from OAM4558g, a randomized phase II study evaluating MetMAb or placebo in combination with erlotinib in advanced NSCLC

Combined treatment of patients with incompletely resected invasive thymoma: A retrospective analysis

Co-expression of steroid and HER2 receptors in breast carcinomas in a large (4,493 cases) population-based Polish study

A pilot study of concurrent chemotherapy (teniposide and carboplatin) combined with whole brain radiotherapy in non-small cell lung cancer patients with brain metastases

A pilot study of concurrent chemotherapy (teniposide and carboplatin) combined with whole brain radiotherapy in non-small cell lung cancer patients with brain metastases

Combination chemotherapy in squamous cell carcinoma of the lung

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Transmission et équation trans-personnelle de l’analyste

Pathophysiology and clinical characteristics of pain in most common locations in cancer patients

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)

Suchergebnisse filtern